One year after submitting a New Drug Application for Azstarys, KemPharm announced this week that the U.S. Food and Drug Administration (FDA) has approved its novel ADHD drug for use in patients six years and older.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,